News for hackers. Stuff that matters.
Re:How the FDA Could Change the Way It Approves Drugs by refurb on Thursday September 03, 2015 @08:45PM (#10168284)
This has somewhat already been solved. Avastin works really well for colorectal cancer, so it was tried in a really small trial in breast cancer. There was a small signal there, so the FDA gave conditional approval with the agreement that the company would run a larger test to confirm the results.

Well, they ran the bigger trial and it showed no benefit at all. The FDA rescinded conditional approval.

Re:How the FDA Could Change the Way It Approves Drugs by danieltillett on Thursday September 03, 2015 @09:41PM (#10168429)
The crazy thing with the current regulations is the company would have been better off financially not ever doing the study. Since doctors can proscribe off-label, if they had not done the larger study they could have kept selling Avastin to breast cancer patients on the sly.

Avastin probably does work for some breast cancer patients if they have a cancer with the right mutations, but if the percentage is a small enough then the large study would not be able to detect this effect in the broad population.